EG
Elston George
Director Financiero
OtherM
Historial del iniciado
Director FinancieroTodavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Discover the detailed record of transactions filed by Elston George, Director Financiero. Insider active across 2 companies, notably EyePoint Pharmaceuticals, Inc.. Aggregated, 20 reports have been recorded. Activity tracked since 9 February 2022. The latest transaction was disclosed on 20 August 2026 (J). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Elston George
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declaraciones20 en total
5000 títulos0Common StockSEC:0001429932-26-000010:0
64.953 títulos0Common StockSEC:0001429932-26-000010:3
5000 títulos0Common StockSEC:0001429932-26-000010:1
64.953 títulos0Common StockSEC:0001429932-26-000010:2
3627 títulos@ 12,93 US$100.0% de su flujoCommon StockSEC:0001429932-26-000008:1
7500 títulos0Common StockSEC:0001429932-26-000008:0
5000 títulos0Common StockSEC:0001429932-26-000006:0
15.285 títulos0Common StockSEC:0001429932-26-000004:0
19.667 títulos0Common StockSEC:0001429932-26-000002:0
5000 títulos0Common StockSEC:0001429932-25-000007:0
20.000 títulos0Common StockSEC:0001429932-25-000005:0
7500 títulos0Common StockSEC:0001562180-25-004193:0
2202 títulos@ 5,68 US$100.0% de su flujoCommon StockSEC:0001562180-25-004193:1
5834 títulos0Common StockSEC:0001562180-25-001135:0
15.000 títulos0Common StockSEC:0001562180-25-000229:0
7500 títulos0Common StockSEC:0001562180-24-004462:0
4967 títulos0Common StockSEC:0001562180-24-001291:0
15.285 títulos0Common StockSEC:0001562180-24-000397:0
5833 títulos0Common StockSEC:0001562180-23-001331:0
4966 títulos0Common StockSEC:0001562180-22-001416:0
About Elston George
Elston George is Chief Financial Officer at EyePoint Pharmaceuticals, Inc. and EyePoint, Inc. He has 16 filings in total. In the 16 sampled recent filings available, the most common transaction nature is option exercise, with buy and sell amounts of EUR 0, and the period runs from 2022-02-11 to 2026-05-27.